Patel, K. R., Rosenbaum, E., Johnson, M., Ryu, H. M., Proudfoot, J. A., Davicioni, E., Spratt, D. E., Sandler, H. M., Roach, M., Rosenthal, S. A., Dicker, A. P., Kapadia, N. S., Correa, R., Zhu, F., Patel, S., Hassanzadeh, C., Efstathiou, J. A., Pugh, S. L., Nguyen, P., Tran, P. T. (2026). Clinico-transcriptomic risk stratification to guide abiraterone treatment intensification in high-risk prostate cancer: A combined analysis of NRG/RTOG 9202, 9413, 9902, and 0521.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5000